Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Moll, U."'
Autor:
Fingerle-Rowson, G., Petrenko, O., Metz, C. N., Forsthuber, T. G., Mitchell, R., Huss, R., Moll, U., Müller, W., Bucala, R.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2003 Aug 01. 100(16), 9354-9359.
Externí odkaz:
https://www.jstor.org/stable/3144213
Autor:
Concin, N., Van Gorp, T., Lorusso, D., Ray-Coquard, I.L., Laenen, A., Zamagni, C., Harter, P., Sehouli, J., Raspagliesi, F., Zeimet, A.G., Lotz, J-P., Salutari, V., Tredan, O., Zeillinger, R., Dobbelstein, M., Moll, U., Kramer, D., Obermayr, E., Braicu, I., Vergote, I.B.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S1226-S1226
Publikováno v:
Cell Death and Differentiation; October 2024, Vol. 31 Issue: 10 p1394-1394, 1p
Autor:
Palacios, G.1, Moll, U. M.1 umoll@notes.cc.sunysb.edu
Publikováno v:
Oncogene. 10/5/2006, Vol. 25 Issue 45, p6133-6139. 7p. 2 Diagrams, 1 Chart, 2 Graphs.
Publikováno v:
Oncogene. 8/7/2006, Vol. 25 Issue 34, p4725-4743. 19p. 5 Diagrams, 1 Chart.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Schulz, R, Streller, F, Scheel, A H, Rüschoff, J, Reinert, M-C, Dobbelstein, M, Marchenko, N D, Moll, U M
Publikováno v:
Cell Death & Disease
Overexpression of the human epidermal growth factor receptor-2 (HER2) in breast cancer strongly correlates with aggressive tumors and poor prognosis. Recently, a positive correlation between HER2 and MIF (macrophage migration inhibitory factor, a tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dae05bb24adfa3e8b68efe4f21426b16
http://resolver.sub.uni-goettingen.de/purl?gs-1/9556
http://resolver.sub.uni-goettingen.de/purl?gs-1/9556
Autor:
Landmann, H, Proia, D A, He, S, Ogawa, L S, Kramer, F, Beißbarth, T, Grade, M, Gaedcke, J, Ghadimi, M, Moll, U, Dobbelstein, M
Publikováno v:
Cell Death & Disease
HSP90 inhibition represents a promising route to cancer therapy, taking advantage of cancer cell-inherent proteotoxic stress. The HSP90-inhibitor ganetespib showed benefit in advanced clinical trials. This raises the need to identify the molecular de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1418fee028c3437ec5a62f50d55a7664
http://resolver.sub.uni-goettingen.de/purl?gs-1/10891
http://resolver.sub.uni-goettingen.de/purl?gs-1/10891
Autor:
Alexandrova, E. M., Yallowitz, A. R., Li, D., Xu, S., Schulz, R., Proia, D. A., Lozano, G., Dobbelstein, M., Moll, U. M.
Publikováno v:
Nature; 7/16/2015, Vol. 523 Issue 7560, p352-356, 5p, 1 Color Photograph, 7 Graphs
Publikováno v:
Cell Death & Differentiation; Apr2014, Vol. 21 Issue 4, p645-654, 10p